CIBC Private Wealth Group
EPZM

CIBC Private Wealth Group’s Epizyme, Inc EPZM Stock Holding History

CIBC Private Wealth Group’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-797,000
Closed -$917K – 1337
2022
Q1 		$917K Sell
797,000
-85,000
-10% -$139K ﹤0.01% 649
2021
Q4 		$2.21M Sell
882,000
-832,500
-49% -$3.27M ﹤0.01% 509
2021
Q3 		$8.78M Buy
1,714,500
+645,600
+60% +$3.92M 0.02% 344
2021
Q2 		$8.88M Buy
1,068,900
+221,500
+26% +$1.87M 0.02% 348
2021
Q1 		$7.38M Buy
847,400
+86,500
+11% +$895K 0.02% 360
2020
Q4 		$8.26M Buy
760,900
+303,996
+67% +$3.75M 0.02% 343
2020
Q3 		$5.45M Buy
+456,904
New +$6.12M 0.02% 353

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIBC Private Wealth Group's EPZM Position: Q2 2022 in Review

CIBC Private Wealth Group sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 797,000 shares — an estimated $917K sold.

CIBC Private Wealth Group first reported a position in EPZM in Q3 2020 and held it in 7 quarters. The position peaked at $8.88M in Q2 2021. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.

  • CIBC Private Wealth Group reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
  • CIBC Private Wealth Group sold 797,000 Epizyme, Inc shares in Q2 2022, an estimated $917K.
  • CIBC Private Wealth Group first reported a position in Epizyme, Inc in Q3 2020 and held it in 7 quarters.
  • CIBC Private Wealth Group's Epizyme, Inc position peaked at $8.88M in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.

Based on CIBC Private Wealth Group's 13F filing for Q2 2022, filed 3 Aug 2022.